Why NBIC? Why human performance enhancement?

A 2001 U.S. workshop with the title “Nanotechnology, Biotechnology, Information Technology and Cognitive Science (NBIC): Converging Technologies for Improving Human Performance” introduced the convergence of various sciences and technologies based on their nanoscale properties. It highlighted BIC as the science and technologies converging on the nanoscale. However many other sciences and technologies with nanoscale components exist, such as chemistry and material sciences. Furthermore the workshop chose human performance enhancement as its case study of application despite various other possible applications that could have been chosen. This paper addresses the questions why the workshop organizers (a) introduced nanoscale as a convergence concept, (b) chose BIC as the convergence examples and (c) chose human performance enhancement as their application. The paper provides some thoughts as to the success and consequences of that strategy.

[1]  B Hobom [Gene surgery: on the threshold of synthetic biology]. , 1980, Medizinische Klinik.

[2]  Roger Brent,et al.  A partnership between biology and engineering , 2004, Nature Biotechnology.

[3]  Fiona Kumari Anne Campbell,et al.  Inciting Legal Fictions: 'Disability's' date with Ontology and the Ableist Body of Law , 2001 .

[4]  Nebojsa Nakicenovic,et al.  Converging Technologies - Shaping the Future of European Societies , 2004 .

[5]  A. Krensky THE NATIONAL INSTITUTE OF HEALTH , .

[6]  David Galef What's the Word? , 2006 .

[7]  G. Wolbring The triangle of enhancement medicine, disabled people, and the concept of health: a new challenge for HTA, health research, and health policy , 2005 .

[8]  Rebecca L. Rawis 'Synthetic Biology' Makes Its Debut , 2000 .

[9]  W. Bean New Bottles for New Wine. , 1959 .

[10]  Bart Walhout,et al.  Constructing Life - Early social reflections on the emerging field of synthetic biology , 2006 .

[11]  Chr. Coenen,et al.  Nanofuturismus: Anmerkungen zu seiner Relevanz, Analyse und Bewertung , 2004 .

[12]  F. Baylis,et al.  The inevitability of genetic enhancement technologies. , 2004, Bioethics.

[13]  Alex M. Andrew Nanomedicine, Volume 1: Basic Capabilities , 2000 .

[14]  Mihail C. Roco,et al.  Converging Technologies for Improving Human Performance , 2003 .

[15]  Robert A Freitas,et al.  What is nanomedicine? , 2005, Disease-a-month : DM.

[16]  Richard J. Herrnstein,et al.  The bell curve :intelligence and class structure in americanlife , 1995 .

[17]  Robert A. Freitas,et al.  Nanomedicine, Volume I: Basic Capabilities , 1999 .

[18]  Anita Silvers,et al.  Disability, Difference, Discrimination: Perspectives on Justice in Bioethics and Public Policy , 1998 .

[19]  C. Sloby,et al.  Discovering the fullerenes , 1997 .

[20]  F. Nielsen,et al.  The Bell Curve: Intelligence and Class Structure in American Life. , 1995 .

[21]  Paras Chopra,et al.  Engineering Life through Synthetic Biology , 2006, Silico Biol..

[22]  ScienceDirect,et al.  Nanomedicine : nanotechnology, biology and medicine. , 2005 .

[23]  Arjun Bhutkar,et al.  Synthetic biology: navigating the challenges ahead. , 2005, The journal of biolaw & business.

[24]  Mere Croft Expert Opinion on Biological Therapy , 2001 .

[25]  Thomas S. Ray,et al.  An Evolutionary Approach to Synthetic Biology: Zen and the Art of Creating Life , 1993, Artificial Life.

[26]  Mihail C. Roco,et al.  Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science , 2003 .

[27]  S. Parker,et al.  Disablism: How to Tackle the Last Prejudice , 2004 .

[28]  K. Eric Drexler,et al.  Engines of Creation: the Coming Era of Nanotechnology , 1986 .

[29]  Philip Ball,et al.  Synthetic biology: Starting from scratch , 2004, Nature.

[30]  Thomas S. Ray An evolutionary approach to synthetic biology: Zen and the art of creating life , 1993 .

[31]  The European Group on Ethics in Science and New Technologies to the European Commission. Adoption of an opinion on ethical aspects of human stem cell research and use. , 2001, Revista de derecho y genoma humano = Law and the human genome review.